← back to search

Jun Wang

University of Science and Technology Liaoning · CN
Area of research
Epidemiology · Infectious Diseases
Research interest
Research interests include Influenza Virus Research Studies, SARS-CoV-2 and COVID-19 Research, RNA and protein synthesis mechanisms, and Viral Infections and Immunology Research.
h-index
60
citations
14,630
works
356
NIH funding
primary concept
email

Recent publications

AI-Driven Antimicrobial Peptide Discovery: Mining and Generation
Accounts of Chemical Research 2025cited by 47position: middledoi
Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir
ACS Central Science 2023cited by 301position: lastdoi
A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations
PLoS Pathogens 2023cited by 28position: middledoi
Structure-based design of SARS-CoV-2 papain-like protease inhibitors
European Journal of Medicinal Chemistry 2023cited by 20position: lastdoi
Additional file 3 of Transcriptome analysis of barley (Hordeum vulgare L.) under waterlogging stress, and overexpression of the HvADH4 gene confers waterlogging tolerance in transgenic Arabidopsis
Figshare 2023cited by 0position: lastdoi
Additional file 1 of Transcriptome analysis of barley (Hordeum vulgare L.) under waterlogging stress, and overexpression of the HvADH4 gene confers waterlogging tolerance in transgenic Arabidopsis
Figshare 2023cited by 0position: lastdoi
Additional file 2 of Transcriptome analysis of barley (Hordeum vulgare L.) under waterlogging stress, and overexpression of the HvADH4 gene confers waterlogging tolerance in transgenic Arabidopsis
Figshare 2023cited by 0position: lastdoi
Additional file 5 of Transcriptome analysis of barley (Hordeum vulgare L.) under waterlogging stress, and overexpression of the HvADH4 gene confers waterlogging tolerance in transgenic Arabidopsis
Figshare 2023cited by 0position: lastdoi
Validation and Invalidation of SARS-CoV-2 Papain-like Protease Inhibitors
ACS Pharmacology & Translational Science 2022cited by 51position: lastdoi
Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
Journal of Medical Virology 2022cited by 48position: lastdoi
Point-of-care SARS-CoV-2 sensing using lens-free imaging and a deep learning-assisted quantitative agglutination assay
Lab on a Chip 2022cited by 28position: middledoi
A unique class of Zn2+-binding serine-based PBPs underlies cephalosporin resistance and sporogenesis in Clostridioides difficile
Nature Communications 2022cited by 27position: middledoi
Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor
ACS Infectious Diseases 2022cited by 26position: lastdoi
Cytopathic Effect Assay and Plaque Assay to Evaluate in vitro Activity of Antiviral Compounds Against Human Coronaviruses 229E, OC43, and NL63
BIO-PROTOCOL 2022cited by 19position: lastdoi
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor
Medicinal Chemistry Research 2022cited by 19position: lastdoi
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Nature Communications 2021cited by 293position: middledoi
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
ACS Central Science 2021cited by 196position: lastdoi
The <i>in vitro</i> antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor
Emerging Microbes & Infections 2021cited by 188position: lastdoi
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
Journal of Medicinal Chemistry 2021cited by 164position: lastdoi
Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity
Journal of the American Chemical Society 2021cited by 150position: lastdoi
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
ACS Infectious Diseases 2021cited by 116position: lastdoi
Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir
ACS Pharmacology & Translational Science 2021cited by 98position: lastdoi
Enterovirus A71 antivirals: Past, present, and future
Acta Pharmaceutica Sinica B 2021cited by 96position: firstdoi
Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
Acta Pharmaceutica Sinica B 2021cited by 86position: lastdoi
Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
Scientific Reports 2021cited by 62position: middledoi
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
Proceedings of the National Academy of Sciences 2021cited by 59position: lastdoi
Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification
Journal of Controlled Release 2021cited by 44position: middledoi
Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein
Journal of Medicinal Chemistry 2021cited by 33position: lastdoi
Influenza AM2 Channel Oligomerization Is Sensitive to Its Chemical Environment
Analytical Chemistry 2021cited by 27position: middledoi
The synergistic antifungal activity of resveratrol with azoles against <i>Candida albicans</i>
Letters in Applied Microbiology 2021cited by 25position: firstdoi

Grants

CSR: Small: Cross-Layer Scheduling to Democratize AI for Foundation Model Inference Serving - An Algorithm-System Co-design Approach
NSF2426368$600,0002025–2028PIRePORTER
RII FEC: Data-Advanced Research and Education to Improve Weather Intelligence and Localized Climate Change Assessment and Resilience in Agriculture-based Communities
NSF2420405$2,999,8942024–2028PIRePORTER
CAREER: Leveraging Virtual Reality (VR) and Artificial Intelligence (AI) to Maximize Skill Transfer in Human-Robot Interaction and Collaboration (HRI/C) for Advanced Construction
NSF2337871$557,3912024–2029PIRePORTER
SHF: Small: Taming Huge Page Problems for Memory Bulk Operations Using a Hardware/Software Co-Design Approach
NSF2400014$400,0002024–2027PIRePORTER
Collaborative Research: CIF: Medium: An Algorithmic Theory of Hamiltonian Dynamics for Sampling, Optimization, and Games
NSF2403392$300,0002024–2028PIRePORTER
CDS&E/Collaborative Research: Data-Driven Inverse Design of Additively Manufacturable Aperiodic Architected Cellular Materials
NSF2245299$249,8292023–2027PIRePORTER
PPoSS: Planning: Data Centric Computing for Scalable Heterogeneous Memory and Storage Systems Architecture
NSF2028481$250,0002020–2023PIRePORTER
SHF: Small: Revamping I/O Architectures Using Machine Learning Techniques on Big Compute Machines
NSF1907765$599,8272019–2026PIRePORTER
SHF: Small: Developing a Highly Efficient and Accurate Approximation System for Warehouse-Scale Computers with the Sub-dataset Distribution Aware Approach
NSF1717388$450,0002017–2023PIRePORTER
SHF: Small: Multi-criteria optimization control for temperature constrained energy efficient data center using fuzzy decision making theory
NSF1527249$369,0922015–2020PIRePORTER
XPS: SDA: Collaborative Research: A Scalable and Distributed System Framework for Compute-Intensive and Data-Parallel Applications
NSF1337244$375,0002013–2018PIRePORTER
CSR: Small: DSA-Cloud: Data Semantics Aware Clouds for High Performance Analytics
NSF1115665$390,9732011–2015PIRePORTER
SOCS: Socially Intelligent Computing to Support Citizen Science
NSF0968470$533,4492010–2014PIRePORTER
CAREER: Data-Intensive HPC Analytics: A Systems Approach Through Extended Interfaces, Data Restructuring and Data-centric Scheduling
NSF0953946$454,9092010–2017PIRePORTER
CPA-ACR: Fast Recovery Using Optimal and Near-Optimal Parallelism in Data-Intensive Computing
NSF0811413$289,9922008–2013PIRePORTER
CSR-PDOS: Energy-Efficient, High-Performance Storage Array Systems
NSF0646911$225,3662006–2010PIRePORTER
Collaborative: CSR-PDOS: Energy Conservation in Storage Systems using Coding Techniques
NSF0646910$50,0002006–2010PIRePORTER
Collaborative: CSR-PDOS: Energy Conservation in Storage Systems using Coding Techniques
NSF0615263$50,0002006–2006PIRePORTER
CSR-PDOS: Energy-Efficient, High-Performance Storage Array Systems
NSF0509480$260,0002005–2006PIRePORTER
An I/O Buffer Cache Architecture for Remote Direct Memory Access
NSF0429995$35,0002004–2007PIRePORTER

Frequent collaborators

Chunlong Ma · University of Arizona45 papers (2013–2022)Yanmei Hu · Kyushu University40 papers (2016–2023)Rami Musharrafieh · University of Arizona16 papers (2016–2021)William F. DeGrado · University of California, San Francisco15 papers (2013–2022)Jiantao Zhang · University of Arizona12 papers (2016–2020)Michael T. Marty · University of Arizona9 papers (2019–2022)Yu Chen · Nanjing University of Chinese Medicine9 papers (2020–2023)Julia A. Townsend · University of Arizona8 papers (2020–2022)Antonios Kolocouris · National and Kapodistrian University of Athens8 papers (2018–2021)M. Sacco · University of South Florida7 papers (2020–2022)Haozhou Tan · Rutgers, The State University of New Jersey7 papers (2021–2023)Yibing Wu · Hebei Medical University6 papers (2013–2019)Robert A. Lamb · Leonardo (United Kingdom)6 papers (2013–2014) · 6 papers (2013–2014) · 6 papers (2020–2021)Yan Xiang · Nanjing University of Chinese Medicine6 papers (2020–2021)Yuanxiang Wang · Shihezi University6 papers (2016–2018)Naoya Kitamura · University of Arizona5 papers (2019–2021)Tommy Szeto · University of Arizona5 papers (2020–2021)Raymond K. Hau · University of Arizona5 papers (2017–2019)